The anti CD47 drugs market is estimated to be valued at USD 0.14 Bn in 2024 and is expected to reach USD 1.7 Bn by 2031, growing at a compound annual growth rate (CAGR) of 42.9% from 2024 to 2031. https://www.zupyak.com/p/4465119/t/the-anti-cd47-drugs-market-is-to-witness-high-growth-due-to-increasing-prevalence-of-cancer